| 英文名称 | 中文名称 | CAS | MF |
|
NALOXONE-3-GLUCURONIDE
|
|
|
C25H29NO10
|
|
Naloxone-3,14-diacetate
|
|
50510-01-5
|
C23H25NO6
|
|
Naloxol 6--D-Glucuronide
|
|
|
C25H31NO10
|
|
NALOXONE METHIODIDE
|
|
93302-47-7
|
C20H24NO4.I
|
|
Naloxone-d5 3-Methyl Ether
|
|
1261082-21-6
|
C20H23NO4
|
|
NALOXONE, [N-ALLYL 2,3-3H]
|
|
|
C19H18NO4T3
|
|
NALOXONE HYDROCHLORIDE DIHYDRATE MM(CRM STANDARD)
|
|
|
|
|
NALOXONE IMPURITY A4,5-ALPHA-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE (NOROXYMORPHONE) EPN(CRM STANDARD)
|
|
|
|
|
NALP1 (NACHT-, LRR- and PYD-Containing Protein 1, DEFCAP, NAC, CARD7, Caspase Recruitment Domain 7) (A)
|
|
|
|
|
Naloxone 3-b-D-Glucuronide
|
纳络酮3-Β-D-葡萄糖醛酸
|
22135-79-1
|
C25H29NO10
|
|
NALOXONE HYDROCHLORIDE BP STANDARD(CRM STANDARD)
|
|
|
|
|
NALOXONE HYDROCHLORIDE ASSAY STANDARD BP(CRM STANDARD)
|
|
|
|
|
NALP3 (NACHT-, LRR- and PYD-Containing Protein 3, Cryopyrin, Cold Autoinflammatory Syndrome 1 Protein, PYPAF1, PYRIN-Containing APAF1-like Protein 1, CIAS1) (A)
|
|
|
|
|
NALOXONE HYDROCHLORIDE EPN(CRM STANDARD)
|
|
|
|
|
NALOXONE MM(CRM STANDARD)
|
|
|
|
|
NALP3 (NACHT-, LRR- and PYD-Containing Protein 3, Cryopyrin, Cold Autoinflammatory Syndrome 1 Protein, PYPAF1, PYRIN-Containing APAF1-like Protein 1, CIAS1)
|
|
|
|
|
naloxone-6-spirohydantoin
|
|
87872-71-7
|
|
|
naloxone receptor
|
|
|
|
|
naloxazone
|
|
73674-85-8
|
|
|
naloxazine
|
|
71786-91-9
|
|
|
NALOXONAZINE DIHYDROCHLORIDE
|
|
82824-01-9
|
C38H44Cl2N4O6
|
|
NALP1, NT (NACHT-, LRR- and PYD-Containing Protein 1, DEFCAP, NAC, CARD7, Caspase Recruitment Domain 7)
|
|
|
|
|
NALOXONE BENZOYLHYDRAZONE
|
|
119630-94-3
|
C26H27N3O4
|
|
NALOXONE USP(CRM STANDARD)
|
|
|
|
|
naloxone-3-O-methyl-oxime
|
|
|
|
|
NALOXONE FLUORESCEIN
|
|
88641-41-2
|
|
|
NALOXONE BENZOYLHYDRAZONE
|
|
|
C26H27N3O4
|
|
Naloxone hydrochloride dihydrate
|
二水合盐酸纳洛酮
|
51481-60-8
|
C19H26ClNO6
|
|
Naloxone hydrochloride
|
盐酸纳洛酮
|
357-08-4
|
C19H22ClNO4
|
|
Naloxyindole
|
|
126580-45-8
|
C25H24N2O3
|
|
Naloxone methylbromide
|
|
|
|
|
NALP1 protein
|
|
|
|
|
NB.BPU10I
|
|
|
|
|
NBC1 (HCO3 Cotransporters 1, pNBC) A
|
|
|
|
|
NBC1 (HCO3 Cotransporters 1)
|
|
|
|
|
NBC3 (HCO3 Cotransporters 3) C
|
|
|
|
|
NBC3 (HCO3 Cotransporters 3) B
|
|
|
|
|
NBC3 (HCO3 Cotransporters 3)
|
|
|
|
|
NBC1 (HCO3 Cotransporters 1) A
|
|
|
|
|
NBC2 (HCO3 Cotransporters 2) A
|
|
|
|
|
NBC1 (HCO3 Cotransporters 1, pNBC)
|
|
|
|
|
NBC3 (HCO3 Cotransporters 3) A
|
|
|
|
|
NBC2 (HCO3 Cotransporters 2)
|
|
|
|
|
NBD
|
|
|
|
|
NALQUATIC
|
|
|
|
|
N-[4-(Amidinosulfamoyl)phenyl]-6-chloro-4-oxo-4H-1-benzopyran-2-carboxamide
|
|
27455-35-2
|
|
|
N-[2-(Amidinothio)propionyl]glycine
|
|
|
|
|
N-Amidinophosphoramidothioic acid O,O-diethyl ester
|
|
10539-37-4
|
|
|
4-[N'-(1-Amidino-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazino]benzenesulfonamide
|
|
47220-10-0
|
|
|
N-(2-Amidinoethyl)-1-methyl-4-[[[1-methyl-4-(formylamino)-1H-pyrrole-2-yl]carbonyl]amino]-1H-pyrrole-2-carboxamide
|
|
56752-53-5
|
|
|
N-amidinooctanamide
|
|
5633-74-9
|
C9H19N3O
|
|
N-amidinomyristamide
|
|
94087-65-7
|
C15H31N3O
|
|
N-((1-(6-amidinobutylhexylcarbamoyl)-3-methyl-1-butylcarbamoyl)methyl)-1-phenyl-2-((8-hydroxy-6,11-dimethyl-1,2,5,6-tetrahydro-4H-2,6-methanobenzazocin-3-yl)methyl)cyclopropanecarboxamide
|
|
|
|
|
N-((1-(5-amidinobutylpentylcarbamoyl)-3-methyl-1-butylcarbamoyl)methyl)-1-phenyl-2-((8-hydroxy-6,11-dimethyl-1,2,5,6-tetrahydro-4H-2,6-methanobenzazocin-3-yl)methyl)cyclopropanecarboxamide
|
|
|
|
|
N-(3-(4-(4-(amidinophenoxy)carbonyl)phenyl)-2-methyl-2-propenoyl)-N-allylglycine
|
|
|
|
|
1-N-amidino-1-N-demethyl-2-hydroxydestomycin A
|
|
96479-74-2
|
|
|
3-(N-(4-amidosulfonylphenyl)aminomethyl)quinoline
|
|
|
|
|
N-amidinomorpholine-4-carboxamidine hydrochloride
|
|
7420-18-0
|
C6H14ClN5O
|
|
N-amidinododecanamide
|
|
5634-27-5
|
C13H27N3O
|
|
N(6)-(amido-3-propyl)adenosine
|
|
104124-24-5
|
|
|
N-amidino-6-chloro-3-[(cyclopropylmethyl)amino]pyrazinecarboxamide
|
|
25670-43-3
|
C10H13ClN6O
|
|
N-AMIDINOBENZAMIDE
|
|
3166-00-5
|
C8H9N3O
|
|
N-AMIDINO-N-(2,3-DIHYDROXY PROPYL)GLYCINE
|
|
|
C6H13N3O4
|
|
N-amidinodecan-1-amide
|
|
27182-51-0
|
C11H23N3O
|
|
N-amidinohexadecan-1-amide
|
|
77440-12-1
|
C17H35N3O
|
|
N-amidinohexanamide
|
|
4456-92-2
|
C7H15N3O
|
|
N-AMIDO-3,5-DIAMINO-6-CHLOROPYRAZINE CARBOXAMIDE
|
|
|
C5H7ClN6O
|
|
Creatine monohydrate
|
一水肌酸
|
6020-87-7
|
C4H11N3O3
|
|
Folic acid
|
叶酸
|
59-30-3
|
C19H19N7O6
|
|
NBC1, Human (Na, HCO3 Cotransporter 1, pNBC) (Control Peptide)
|
|
|
|
|
NBC3, HUMAN, 19AA WITHIN CYTOPLASMIC CT
|
|
|
|
|
NBC2, HUMAN, 20AA WITHIN CYTOPLASMIC CT
|
|
|
|
|
NBC3, HUMAN, 16AA WITHIN CYTOPLASMIC NT
|
|
|
|
|
NBC1, HUMAN, 20AA WITHIN CYTOPLASMIC NT
|
|
|
|
|
NBC3, Human (HCO3 Cotransporters 3) A
|
|
|
|
|
NBC3, Human (HCO3 Cotransporters 3)
|
|
|
|
|
NBC2, Human (HCO3 Cotransporters 2)
|
|
|
|
|
N-(2-AMINO-ETHYL)-NICOTINAMIDE DIHYDROCHLORIDE
|
|
|
C8H13Cl2N3O
|
|
1-[N-(4-AMINOPHENYL)AMINO]-2-(2,2,3,3-TETRAFLUOROPROPANOYL)CYCLOPENTENE
|
|
|
C14H14F4N2O
|
|
N-(1-AMINOMETHYL-CYCLOPENTYL)-2-CHLORO-ACETAMIDE
|
|
912763-44-1
|
C8H15ClN2O
|
|
N-[2-AMINO-4-(MORPHOLIN-4-YLSULFONYL)PHENYL]-N-ETHYLAMINE
|
|
|
C12H19N3O3S
|
|
N-(4-AMINOPYRIMIDIN-2-YL)-N-METHYLAMINE
|
|
|
C5H8N4
|
|
N-AMINO-6-[(3,5-DI(DIHYDROXYBORYL)PHENYL)CARBONYLAMINO]HEXANAMIDE HCL
|
|
|
C13H21B2N3O6
|
|
N-(2-[3-(5-AMINO-1-METHYL-1H-PYRAZOL-4-YL)-5-METHYL-4H-1,2,4-TRIAZOL-4-YL]ETHYL)-3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINAMINE
|
|
|
C15H16ClF3N8
|
|
1-[N-(2-AMINOPHENYL)AMINO]-2-(TRIFLUOROACETYL)CYCLOHEXENE
|
|
|
C14H15F3N2O
|
|
N-[4-(AMINOMETHYL)BENZYL]RHODAMINE 6G-AMIDE BIS(TRIFLUOROACETATE)
|
|
591742-78-8
|
C34H36N4O2C4H2F6O4
|
|
N-[3-(2-AMINO-4-METHYLPHENOXY)PHENYL]ACETAMIDE
|
|
|
C15H16N2O2
|
|
N-(3-AMINO-2,6-DIBROMO-4-CHLOROPHENYL)BUTANAMIDE
|
|
|
C10H11Br2ClN2O
|
|
N-(3-AMINOPROPYL)-2-BUTENE-1,4-DIAMINE
|
|
|
C7H17N3
|
|
N-[2-(AMINOCARBONOTHIOYL)PHENYL]-2-FURAMIDE
|
|
|
C12H10N2O2S
|
|
3-[N-(4-AMINO)BENZYL-2-PYRROLIDINONE]-4'-N-BOC-SPIRO-PIPERIDINE
|
|
|
|
|
N-(6-AMINO-2,4-DIOXO-1-PROPYL-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL)-N-BUTYL-4-CHLOROBUTANAMIDE
|
|
|
C15H25ClN4O3
|
|
N-[4-(AMINOSULFONYL)PHENYL]-2-[(5E)-5-(4-METHOXYBENZYLIDENE)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-3-YL]ACETAMIDE
|
|
|
C19H17N3O5S3
|
|
N-[3-(2-AMINO-6-CHLOROPHENOXY)PHENYL]-N,N-DIMETHYLAMINE
|
|
937604-75-6
|
C14H15ClN2O
|
|
N-(3-[4-AMINO-3-(TRIFLUOROMETHYL)PHENOXY]PHENYL)-N,N-DIMETHYLAMINE
|
|
946663-17-8
|
C15H15F3N2O
|
|
N-(4-AMINO-PHENYL)-N-METHYL-BENZAMIDE
|
|
|
C14H14N2O
|
|
N-[1-AMINO-6-METHYL-2-OXO-5-(1H-PYRAZOL-5-YL)-1,2-DIHYDRO-3-PYRIDINYL]-4-METHYLBENZENECARBOXAMIDE
|
|
|
C17H17N5O2
|
|
N-[3-(AMINOMETHYL)PHENYL]-N-METHYLACETAMIDE HYDROCHLORIDE
|
|
|
C10H15ClN2O
|
|
N1-(4-AMINO-2-CHLORO-6-FLUOROPHENYL)ACETAMIDE
|
|
|
C8H8ClFN2O
|
|
N-[2-(2-AMINO-6-CHLOROPHENOXY)ETHYL]-N-METHYL-N-PHENYLAMINE
|
|
|
C15H17ClN2O
|